Advertisement

L-Dopa Responsive Dystonia/Infantile Parkinsonism Associated with Mutations at the Human Tyrosine Hydroxylase Locus

  • Torgeir Flatmark
  • Bjørg Almås
  • Anne P. Døskeland
Part of the Advances in Behavioral Biology book series (ABBI, volume 53)

Abstract

The L-DOPA responsive dystonias (DRD) represent a group of hereditary neurometabolic disorders with some common clinical features, but with a locus heterogeneity and different genotypes. The first described and best characterized is the hereditary progressive dystonia (HPD/DRD)(for review, see Segawa, 2000), an autosomal dominantly inherited motoric dysfunction caused by mutations at the GTP cyclohydrolase I (GCH 1; EC 3.5.4.16) locus on chromosome 14 (gen map locus 14q22.1-q22.2)(Ichinose et al., 1994). An autosomal recessive form of DRD was later described and found to be associated with a point mutation (Q381K) at the human tyrosine hydroxylase (hTH; EC 1.14.16.2) locus (gene map locus 11pl5.5)(Lüdecke et al., 1995; Knappskog et al., 1995). Subsequently, a recessively inherited L-DOPA responsive infantile parkinsonism (DRIP), also caused by a point mutation (L205P) at the hTH locus, was reported (Lüdecke et al., 1996). Both hTH mutations were considered sufficient to explain the deficient function of the hydroxylase, the attendant neurometabolic pattern and the resultant clinical signs and symptoms. A total of twelve different mutations at the hTH locus are now known to be associated with DRD/DRIP (Table 1). The patients with mutations at the hTH locus show larger variations in and often more severe clinical phenotypes as well as an earlier onset than in the classical Segawa’s syndrome (HPD/DRD). The disease is manifested only in homozygotes and compound heterorygote, whereas the autosomal dominant form of HPD/DRD is observed also in heterozygotes.

Keywords

Tyrosine Hydroxylase Autosomal Recessive Form Autosomal Dominant Form Tyrosine Hydroxylase Gene Facial Mimicry 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bräutigam, C, Steenbergen-Spanjers, G.C.H., Hoffmann, G.F., Dionisi-Vici, C., van den Heuvel, L.P.W.J., Smeitink, J.A.M., and Wevers, R.A., 1999, Biochemical and molecular genetic characteristics of the severe form of tyrosine hydroxylase deficiency, Clin. Chem. 45:2073.PubMedGoogle Scholar
  2. de Lonlay, P., Nassogne, M.C., van Gennip, A.H., van Cruchten, A.C., Billatte de Villemeur, T., Cretz, M., Stoll, C., Launay, J.M., Steenberger-Spante, G.C.V., van den Heuvel, L.P.W., Wevers, R.A., Saudubray, J.M., and Abeling, N.G.G.M., 2000, Tyrosine hydroxylase deficiency unresponsive to L-dopa treatment with unusual clinical and biochemical presentation, J. Inherit. Metab. Dis. 23:819.CrossRefGoogle Scholar
  3. Fiatmark, T., and Stevens, R.C., 1999, Structural insight into the aromatic amino acid hydroxylases and their disease-related mutant forms, Chem. Rev. 99:2137.CrossRefGoogle Scholar
  4. Flatmark, T., 2000, Catecholamine biosynthesis and physiological regulation in neuroendocrine cells, Acta hysiol. Scand. 168:1.CrossRefGoogle Scholar
  5. Fukami, M.H., Haavik, J., and Flatmark, T., 1990, Phenylalanine as substrate for tyrosine hydroxylase in bovine drenal chromaffin cells, Biochem. J. 268:525.PubMedGoogle Scholar
  6. Furukawa, Y., Graf, W.D., Wong, H., Shimadzu, M., and Kish, S.J., 2001, Dopa-responsive dystonia simulating spastic paraplegia due to tyrosine hydroxylase (TH) gene mutations, Neurology 56:260.PubMedCrossRefGoogle Scholar
  7. Ichinose, H., Ohye, T., Takahashi, E., Seki, N., Hori, T., Segawa, M., Nomura, Y., Endo, K., Tanaka, H., Tsuji, S., Fujita, K., and Nagatsu, T., 1994, Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene, Nature Genet. 8:236.PubMedCrossRefGoogle Scholar
  8. Knappskog, P.M., Flatmark, T., Mallet, J., Lüdecke, B., and Bartholomé, K., 1995, Recessively inherited L- DOPA-responsive dystonia caused by a point mutation (Q381K) in the tyrosine hydroxylase gene, Hum. Mol. Genet. 4:1209.PubMedCrossRefGoogle Scholar
  9. Kobayashi, K., Morita, S., Sawada, H., Mizuguchi, T., Yamada, K., Nagatsu, I., Hata, T., Watanabe, Y., Fujita, K., and Nagatsu, T., 1995, Targeted disruption of the tyrosine hydroxylase locus results in severe catecholamine depletion and perinatal lethality in mice, J. Biol. Chem. 270:27235.PubMedCrossRefGoogle Scholar
  10. Lüdecke, B., Dworniczak, B., and Bartholomé, K., 1995, A point mutation in the tyrosine hydroxylase gene associated with Segawa’s syndrome, Hum. Genet. 95:123.PubMedGoogle Scholar
  11. Lüdecke, B., Knappskog, P.M., Clayton, P.T., Surtees, R.A.H., Clelland, J.D., Heales, S.J.R., Brand, M.P., Bartholomé, K., and Flatmark, T., 1996, Recessively inherited L-DOPA-responsive parkinsonism in infancy caused by a point mutation (L205P) in the tyrosine hydroxylase gene, Hum. Mol. Genet. 5:1023.PubMedCrossRefGoogle Scholar
  12. Lüdecke, B., Dworniczak, B., and Bartholomé, K., 1995, A point mutation in the tyrosine hydroxylase gene associated with Segawa’s syndrome, Hum. Genet. 95:123.PubMedGoogle Scholar
  13. Segawa, M., 2000, Hereditary progressive dystonia with marked diurnal fluctuation, Brain Dev. 22:S65.CrossRefGoogle Scholar
  14. Scriver, C.R., and Waters, P.J., 1999, Monogenic traits are not simple: lessons from phenylketonuria, Trends Genet. 15:267.PubMedCrossRefGoogle Scholar
  15. Swaans, R.J., Rondot, P., Renier, W.O., van den Heuvel, L.P., Steenbergen-Spanjers, G.C., and Wevers, R.A., 2000, Four novel mutations in the tyrosine hydroxylase gene in patients with infantile parkinsonism, Ann. Hum. Genet. 64:25.PubMedCrossRefGoogle Scholar
  16. van den Heuvel, L.P.W.J., Luiten, B., Smeitink, J.A.M., deRijk-van Andel, J.F., Hyland, K., Steenbergen- Spanjers, G.C.H., Janssen, R.J.T., and Wevers, R.A., 1998, A common point mutation in the tyrosine hydroxylase gene in autosomal recessive L-DOPA-responsive dystonia in the Dutch population, Hum. Genet. 102:644.PubMedCrossRefGoogle Scholar
  17. Wevers, R.A., deRijk-van Andel, J.F., Bräutigam, C., Geurtz, B., van den Heuvel, L.P., Steenbergen-Spanjers, G.C., Smeitink, J.A., Hoffmann, G.F., and Gabreels, F.J., 1999, A review of biochemical and molecular genetic aspects of tyrosine hydroxylase deficiency including a novel mutation (291delC), J. Inherit. Metab. Dis. 22:364.PubMedCrossRefGoogle Scholar
  18. Zhou, Q.Y., and Palmiter, R.D., 1995, Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic, Cell 83:1197.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2002

Authors and Affiliations

  • Torgeir Flatmark
    • 1
  • Bjørg Almås
  • Anne P. Døskeland
  1. 1.Department of Biochemistry and Molecular BiologyUniversity of BergenBergenNorway

Personalised recommendations